Regression of experimental NIS-expressing breast cancer brain metastases in response to radioiodide/gemcitabine dual therapy

about

Regression of experimental NIS-expressing breast cancer brain metastases in response to radioiodide/gemcitabine dual therapy

Item

http://www.wikidata.org/entity/Q37688145

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Regression of experimental NIS ...... odide/gemcitabine dual therapy

@en

Regression of experimental NIS ...... dide/gemcitabine dual therapy.

@nl

type

Item

label

Regression of experimental NIS ...... odide/gemcitabine dual therapy

@en

Regression of experimental NIS ...... dide/gemcitabine dual therapy.

@nl

prefLabel

Regression of experimental NIS ...... odide/gemcitabine dual therapy

@en

Regression of experimental NIS ...... dide/gemcitabine dual therapy.

@nl

P1476

Regression of experimental NIS ...... odide/gemcitabine dual therapy

@en

P2093

Abhijit De

http://www.w3.org/2001/XMLSchema#string

Andrea Reyna-Neyra

http://www.w3.org/2001/XMLSchema#string

Corinne Renier

http://www.w3.org/2001/XMLSchema#string

Deshka Foster

http://www.w3.org/2001/XMLSchema#string

Hannes Vogel

http://www.w3.org/2001/XMLSchema#string

Irene Wapnir

http://www.w3.org/2001/XMLSchema#string

John Do

http://www.w3.org/2001/XMLSchema#string

Nancy Carrasco

http://www.w3.org/2001/XMLSchema#string

Victor Tse

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of the human sodium lodide symporter

Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer

The sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapies

Cloning and characterization of the thyroid iodide transporter

Dose translation from animal to human studies revisited

Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group.

Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase I trial and intracellular drug incorporation study.

The relation between deoxycytidine kinase activity and the radiosensitising effect of gemcitabine in eight different human tumour cell lines

Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I study

In vitro radionuclide therapy and in vivo scintigraphic imaging of alpha-fetoprotein-producing hepatocellular carcinoma by targeted sodium iodide symporter gene expression.

P304

54811-54824

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.10238

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stefanie S Jeffrey

P577

2016-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27363025

http://www.w3.org/2001/XMLSchema#string

P932

5342383

http://www.w3.org/2001/XMLSchema#string